about
Acetylcholinesterase inhibitor treatment for myasthenia gravisCellular and synaptic mechanisms of anti-NMDA receptor encephalitisFollicular Helper T (Tfh) Cells in Autoimmune Diseases and Allograft RejectionAnimal models of myasthenia gravis: utility and limitationsA Double-Blinded, Randomized, Placebo-Controlled Trial to Evaluate Efficacy, Safety, and Tolerability of Single Doses of Tirasemtiv in Patients with Acetylcholine Receptor-Binding Antibody-Positive Myasthenia GravisActivation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseasesEffects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravisSorting receptor Rer1 controls surface expression of muscle acetylcholine receptors by ER retention of unassembled alpha-subunitsAn altered phenotype in a conditional knockout of Pitx2 in extraocular muscle.Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn.Identifying alternative hyper-splicing signatures in MG-thymoma by exon arrays.Elimination of Schistosoma mansoni Adult Worms by Rhesus Macaques: Basis for a Therapeutic Vaccine?Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europeCarbonic anhydrase III is insufficient in muscles of myasthenia gravis patients.Prediction of acute multiple sclerosis relapses by transcription levels of peripheral blood cells.Antigenic structure of the human muscle nicotinic acetylcholine receptor main immunogenic regionMyasthenia gravis presenting as isolated respiratory failure: a case report.Improved methodology to obtain large quantities of correctly folded recombinant N-terminal extracellular domain of the human muscle acetylcholine receptor for inducing experimental autoimmune myasthenia gravis in rats.Extracorporeal immunoglobulin elimination for the treatment of severe myasthenia gravis.Mechanisms of Autoantibody-Induced Pathology.Specific immunotherapy of experimental myasthenia gravis by a novel mechanism.RNA expression analysis of passive transfer myasthenia supports extraocular muscle as a unique immunological environment.Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model studyRepetitive nerve stimulation of facial and hypothenar muscles: relative sensitivity in different myasthenia gravis subgroups.Myasthenia gravis-like syndrome presenting as a component of the paraneoplastic syndrome of lung adenocarcinoma in a nonsmokerAcetylcholine receptor-alpha subunit expression in myasthenia gravis: a role for the autoantigen in pathogenesis?The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature.Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine.Intermittent weakness and mediastinal weakeningOcular myasthenia gravis: a review.Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis.Comparison of clinical manifestations between patients with ocular myasthenia gravis and generalized myasthenia gravis.Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina.Novel complement inhibitor limits severity of experimentally myasthenia gravisMyasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays.DBC1 is a suppressor of B cell activation by negatively regulating alternative NF-κB transcriptional activity.A case of Sheehan's syndrome that manifested as bilateral ptosis.Antigen-specific immunotherapeutic vaccine for experimental autoimmune myasthenia gravisTargeting therapy to the neuromuscular junction: proof of concept.Deficits in endogenous adenosine formation by ecto-5'-nucleotidase/CD73 impair neuromuscular transmission and immune competence in experimental autoimmune myasthenia gravis.
P2860
Q24193114-3142AE64-A005-48C7-98D2-2975459B0AB9Q24620536-E3E97ACF-66C6-40E4-834C-A0CB2FAEC832Q26738329-030661BD-E04C-4B39-A9AB-74E654ABB001Q26750632-F329D81C-8C6A-4220-B3DF-F95A5AC6E9C4Q28258367-D6D07B12-F619-4EEA-9FFC-378CB2D621A5Q28260224-5A8CD365-978A-4957-8BC1-2BB9DF2D3E3FQ28539518-AFDE4107-39AE-4627-BE54-BE33F7AEC083Q28594188-FD35688E-EA7C-40D7-9269-D339F079FEC9Q30620542-456307AC-1263-4206-A255-49244E467442Q33319667-C9E58F7D-052A-40CF-832D-9FD30F53EEFDQ33342793-D43E27E3-CC53-403C-91C8-060F27CFDB02Q33372341-A7425E9B-7608-406B-8910-C784AFC24EADQ33419638-DCE19C8F-0A4E-478B-A229-C79E214075E9Q33419952-60D6E80A-2F37-4D7C-BB30-1C9435E5A6AAQ33485522-E505B39F-E3A0-43AE-A179-617B1E15E748Q33598797-E059C018-7D33-4B59-831A-89E66C19C588Q33691568-4956DC05-01F9-4C42-A4A7-F5074EC2EC38Q33701244-AC806971-3217-4F79-A2A1-21F1D76A1936Q33734287-02E2269C-8D6C-4FEB-B014-9F7861DB93FFQ33740580-052405C6-1C3A-4123-B14E-BC8E3C07AC65Q33831279-6222EEE8-5BF0-43D9-B7FA-B98738205C70Q33915924-40D8AFB1-2AEC-4D13-8335-3C47F0DB7EA6Q33933202-B6CAE4AD-0472-49BD-8F63-7225382D0905Q34026134-2AAEC966-A420-4406-BD8A-C9AFAF7747A9Q34032709-CAB45C75-2BE8-4B3D-923A-6CC6E5D1E005Q34079029-CC916791-9374-40AB-A7DF-01C724543563Q34240032-60B68A02-F4C1-4EC9-9BF3-1CE82D9D5FBAQ34338594-463E5F8C-217B-4F77-BCCD-6A79EF9410E2Q34381049-20774898-C5A4-4CC1-9AF7-59CEAE2EF4FBQ34450858-48F71ECA-E0F7-419D-901D-66121CE2B795Q34533028-C5B03237-BCE4-4503-8AB8-D811FCD232C4Q34575021-F9C17F7D-7713-4B13-A0B6-F0AA90E3BBC2Q34603641-7E4303EC-E553-4073-8930-241EDA5BFEE7Q34604158-4A41B057-F16A-4F13-AD22-763C3AEEFA57Q34618619-EF8626C8-3801-4C93-AEA2-E95BA22D40E6Q34653221-71D9A319-3515-4127-80E8-369AEF1FB681Q34753526-8DEC4B33-35BC-4218-AF0D-22919AEF71ECQ34755933-F2913460-E610-486F-A0AA-4AEFBF30CFC8Q34974981-61F28548-FCE4-4A88-90F0-39F94C17A19CQ35067400-3532B310-EB78-47A2-84AD-C264F57BD0A1
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Myasthenia gravis: past, present, and future
@ast
Myasthenia gravis: past, present, and future
@en
Myasthenia gravis: past, present, and future
@nl
type
label
Myasthenia gravis: past, present, and future
@ast
Myasthenia gravis: past, present, and future
@en
Myasthenia gravis: past, present, and future
@nl
prefLabel
Myasthenia gravis: past, present, and future
@ast
Myasthenia gravis: past, present, and future
@en
Myasthenia gravis: past, present, and future
@nl
P2093
P2860
P3181
P356
P1476
Myasthenia gravis: past, present, and future
@en
P2093
Bianca M Conti-Fine
Henry J Kaminski
Monica Milani
P2860
P304
P3181
P356
10.1172/JCI29894
P407
P577
2006-11-01T00:00:00Z